Does adjunctive hemoadsorption with CytoSorb affect survival of COVID-19 patients on ECMO? A critical statement : Thomas Köhler, Elke Schwier, Dietrich Henzler, Claas Eickmeyer ; Department of Anesthesiology, Surgical Intensive Care, Emergency and Pain Medicine, Ruhr University Bochum, Klinikum Herford, Herford, Germany
Cyhoeddwyd yn: | Journal of Critical Care 66(2021)S. 187-188 |
---|---|
Prif Awduron: | Köhler, Thomas (Awdur), Schwier, Elke (Awdur), Henzler, Dietrich (Awdur), Eickmeyer, Claas (Awdur) |
Fformat: | Erthygl |
Iaith: | English |
Cyhoeddwyd: |
2021
|
Pynciau: | |
Mynediad Ar-lein: | https://doi.org/10.1016/j.jcrc.2021.07.011 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314144/ |
Eitemau Perthynol: | In:
Journal of Critical Care |
Eitemau Tebyg
-
High-dose CytoSorb hemoadsorption is associated with improved survival in patients with septic shock : a retrospective cohort study
gan: Schultz, Philipp, et al.
Cyhoeddwyd: (2021) -
Hemoadsorption in the critically ill - Final results of the International CytoSorb Registry
gan: Hawchar, Fatime, et al.
Cyhoeddwyd: (2022) -
Hemoadsorption with CytoSorb and the early course of linezolid plasma concentration during septic shock
gan: Köhler, Thomas, et al.
Cyhoeddwyd: (2022) -
Therapeutic Modulation of the Host Defense by Hemoadsorption with CytoSorb-Basics, Indications and Perspectives-A Scoping Review
gan: Köhler, Thomas, et al.
Cyhoeddwyd: (2021) -
The impact of the COVID-19 pandemic on non-COVID induced sepsis survival
gan: Unterberg, Matthias, et al.
Cyhoeddwyd: (2022)